Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305)
Author(s) -
Roy M. Gulick,
Timothy Wilkin,
Ying Qing Chen,
Raphael J. Landovitz,
K. Rivet Amico,
Alicia Young,
Paul G. Richardson,
Mark A. Marzinke,
Craig W. Hendrix,
Susan H. Eshleman,
Ian McGowan,
Leslie M Cottle,
Adriana Andrade,
Cheryl Marcus,
Karin L. Klingman,
Wairimu Chege,
Alex R. Rinehart,
James F. Rooney,
P. Andrew,
Robert A. Salata,
Manya Magnus,
Jason E. Farley,
Albert Liu,
Ian Frank,
Ken Ho,
Jorge Santana,
Joanne D. Stekler,
Marybeth McCauley,
Kenneth H. Mayer
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/m2r7-rg29
Subject(s) - maraviroc , tolerability , human immunodeficiency virus (hiv) , medicine , virology , pharmacology , psychology , adverse effect
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom